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DNA is a chemically reactive molecule that is subject to many diﬀerent covalent modiﬁcations from sources that are both
endogenous and exogenous in origin. The inherent instability of DNA is a major obstacle to genomic maintenance and contributes
in varying degrees to cellular dysfunction and disease in multi-cellular organisms. Investigations into the chemical and biological
aspects of DNA damage have identiﬁed multi-tiered and overlapping cellular systems that have evolved as a means of stabilizing
the genome. One of these pathways supports DNA replication events by in a sense adopting the mantra that one must “make the
best of a bad situation” and tolerating covalent modiﬁcation to DNA through less accurate copying of the damaged region. Part
of this so-called DNA damage tolerance pathway involves the recruitment of specialized DNA polymerases to sites of stalled or
collapsed replication forks. These enzymes have unique structural and functional attributes that often allow bypass of adducted
template DNA and successful completion of genomic replication. What follows is a selective description of the salient structural
features and bypass properties of specialized DNA polymerases with an emphasis on Y-family members.
1.Introduction
The ability to replicate covalently modiﬁed or “damaged”
DNA and unusual secondary structures in template DNA
(i.e., non-B DNA conformations) is critical to the survival
and evolution of all biological systems. Highly accurate
B-family DNA polymerases are the primary means of
replicating eukaryotic genomes with few mistakes (e.g., error
rates of 10−4−10−7), although subsequent mismatch repair
activity improves the ﬁdelity of replication about 100-fold.
Covalent modiﬁcation of nucleic acids can disrupt normal
replication processing of the heritable material. Of course,
damage to DNA can be recognized and removed from the
genome prior to replication but this repair capacity is not
perfect and lesions do persist in the genome during S-phase.
Damage signals that occur during replication (S-phase)
and postreplication (G2/M phase) can activate signaling
pathways that ultimately recruit a set of specialized DNA
polymerases to the replication fork. These enzymes provide
the cell with a means of “tolerating” the modiﬁed residue
by catalyzing DNA synthesis opposite a number of diﬀerent
lesions, as well as non-B form DNA secondary structures
that can inhibit normal replication. The outcome of this
specialized DNA synthesis reaction can be accurate and pro-
mote cell survival or it can be mutagenic, which often proves
deleterious to cellular homeostasis. A precise description of
how bypass polymerases from diﬀerent organisms function
to tolerate damage to the genome is a fundamental aspect
of understanding mechanisms of mutagenesis. We describe
results that have helped deﬁne the potential ramiﬁcations of
certain DNA lesions to the replication machinery.
Life is dependent upon accurate replication or “copying”
of DNA by enzymes called DNA polymerases [1–3]. The
same chemical reaction is utilized to replicate the genome
of all organisms studied to date, namely, nucleophilic attack
of a deprotonated 3 -oxygen atom on the primer terminus
upon the α-phosphate of an incoming dNTP [4]. Related
organisms tend to share more similarities in terms of the
enzymes and proteins associated with copying DNA, with
some features more highly conserved than others. Enzymatic2 Journal of Nucleic Acids
redundancy with functional distinction and complex path-
way overlap are overarching themes describing how cells
tolerate DNA damage [5, 6]. A careful balance is needed
to ensure that mechanisms primarily retained to “protect”
the genome do not result in unnecessary mutagenic events
and/or cell death.
Numerous types of chemical modiﬁcations to DNA
have been identiﬁed (Figure 1) and many agents that are
known to damage DNA are also carcinogens [8, 9]. Bio-
chemical analysis of DNA polymerase activity has shown
that these enzymes utilize a series of molecular checkpoints
that typically promote formation of “Watson-Crick” base
pairing geometry and, therefore, stable propagation of DNA
[10]. One can easily imagine that changing the chemical
structure of DNA will alter the catalytic properties of DNA
polymerases. Some DNA polymerases show less tolerance to
covalent modiﬁcation of DNA, including the B-family DNA
polymerases such as, pols δ and ε, both of which possess
ex onucleaseactivity .Theseenzymesareabletobypasscertain
DNA lesions [11, 12]a n dt h i sb y p a s sa c t i v i t yp r o b a b l y
bears relevance towards what occurs in vivo (Figure 2).
When considering translesion DNA synthesis in general,
it is believed that nonessential DNA polymerases, such
as the Y-family, perform bypass more eﬃciently than the
so-called “high ﬁdelity” exonuclease containing enzymes.
The most important questions to ask related to DNA
adduct bypass pertain to how the presence of DNA adducts
produce changes in nucleotide selectivity (i.e., ﬁdelity) due
to altered structural features and/or changes in catalytic rate
constants for individual DNA polymerases. Most research
on translesion DNA synthesis attempts to focus on DNA
modiﬁcations that have been correlated with increased
mutagenesis and/or the manifestation of disease [13]. Much
of the work done during the last decade has focused on
understandinghownonessentialpolymerases,mostofwhich
do not possess exonuclease activity, catalyze DNA synthesis
opposite damaged DNA [14]. Numerous exemplary eﬀorts
fromthegroups of Woodgate, W.Yang,Friedberg, Lehmann,
Loeb, Geacintov, Levneh, Nohmi, Walker, Goodman, the
Prakashs, Burgers, Lloyd, and Kunkel and our long-time
collaborators at Vanderbilt—M. Egli, C. J. Rizzo, L. J.
Marnett, T. M. Harris, and M. P. Stone—to name a few
individuals have increased our understanding of translesion
DNA synthesis in tremendous ways. Of the nonessential
pols studied to date, the Y-family DNA polymerases seem
to be the primary means of tolerating genotoxic insults
through direct bypass of adducts during S-phase and the
G2/M phase transition, although the B-family members
pol II and pol ξ also play important roles in prokaryotic
and eukaryotic cells, respectively. While the activity of
nonessential or “specialized” DNA polymerases can suppress
damage-induced mutagenesis [15], this suppression at sites
of damage can still lead to nontargeted mutations elsewhere
[16]. Indeed, the misregulation of their activity is believed to
participate in mutagenic events and antagonistic pleiotropy
associated with tumorigenesis and aging because they do
not possess exonuclease “proofreading” ability and they
are generally more likely to make mistakes on undamaged
template DNA (Figure 2)[ 17–24]. These specialized DNA
polymerases generally share the following attributes: (i) they
possess no intrinsic exonuclease activity (except for pol II),
(ii) they have spacious active sites with fewer structural and
kinetic checks upon the nascent base pair, (iii) they exhibit
reduced processivity, (iv) the error rates with unmodiﬁed
template DNA are higher than for replicative counterparts,
and (v) there are damage-inducible signaling pathways that
recruit them to replication foci. Structurally speaking, the
overall domain architecture of Y-family DNA polymerases
is similar to that of other polymerases, including B-family
members (Figure 2). However, there are several important
diﬀerences that are obvious from the crystal structures. For
example, the active site of Y-family DNA polymerases is
much larger and more exposed to solvent than B-family
counterparts. The Y-family also possesses the unique “little
ﬁnger” domain, as well as N-terminal extensions such as
the N-digit of REV1 and the N-clasp of human pol κ [14].
Some elements of so-called translesion or specialized DNA
synthesis events are relatively clear now. For example, the
genetic, biological, and biochemical data supporting the pre-
eminent importance of human pol η in the largely accu-
rate bypass of UV-induced cyclobutane pyrimidine dimers
(CPDs) is very strong [25–28]. Still, there remain many
outstanding questions of interest related to mechanisms that
promote DNA damage tolerance. Following is a summary
of the literature concerning how these specialized DNA
polymerases perform synthesis across DNA adducts.
2. Bypassof AbasicSitesand
Small OxidativeLesions
Perhaps the most prevalent form of genetic insult in cells is
loss of a purine/pyrimidine base to generate an abasic site
(Figure 1(a))[ 29, 30]. Generation of abasic sites can occur
enzymatically through the action of glycosylases, from spon-
taneous hydrolysis at the glycosidic bond or from reactions
withexogenouschemicalagents[31,32].Abasicsitesprovide
no purinic or pyrimidinic moiety for DNA polymerases to
use as a template during replication. Naturally occurring
deoxyribose abasic sites exist in equilibrium between the
ring-closed α-a n dβ-hemiacetals (99%) and ring-opened
aldehyde or hydrated aldehyde (<1%), which has led to
the common practice of studying a stable tetrahydrofuran
(THF) moiety instead of a true abasic site. Mechanistic
studies with the THF analogue (of natural abasic sites)
highlight the concept that if the enzyme does not encounter
a base then the normal catalytic pathway is diverted into
a chemical path that generally results in the incorporation
of dATP opposite the THF abasic site (i.e., the “A-rule”)
[33]. In Escherichia coli cells, pol V appears to provide the
most eﬃcient means of bypassing abasic THF sites, with
insertion of dATP being the preferred catalytic event [34].
In contrast to events in E. coli, eukaryotic cells appear to rely
upon a combination of DNA polymerases to bypass abasic
moieties. DNA polymerases δ and REV1, in combination
with pol ξ,b y p a s sa b a s i cs i t e sin vitro and in vivo [35, 36].
Recently, yeast pol ε was reported to bypass abasic sites in
vitro [37]. Dpo4 inserts dATP opposite the THF moietyJournal of Nucleic Acids 3
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Figure 1:OverviewofDNAadducts.ThenumberofDNAadductsformedthroughinteractionswithreactivechemicalsorionizingradiation
is vast, and more thorough reviews have been performed elsewhere [7]. We have chosen to focus on some of the most thoroughly studied
DNA adducts, in terms of how the adduct aﬀects DNA polymerase structure and function. A, abasic sites and 8-oxodG; B, minor groove
N
2-dG adducts; C, major groove O
6-dG and N
6-dA adducts; D, exocyclic dG adducts. Adduct stereospeciﬁcity is not shown in structures of
of B[a]P DNA adducts.4 Journal of Nucleic Acids
DNA damage/replication stress
Complex signaling mechanisms recruit specialized accessory
factors (e.g. Y-family pols) to replication fork where B-family
pol catalysis has been perturbed
Specialized polymerases
• Lower accuracy
against unmodiﬁed
DNA
• Higher eﬃciency
against damage
• Fidelity against damage
depends on pol
B-family polymerase
• High accuracy
against unmodiﬁed
DNA
• Low eﬃciency
against damage
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• More likely to result in apoptosis
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• More likely to bypass damage
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• More mutations if misregulated
Figure 2: Schematic overview of DNA damage tolerance and two families of DNA polymerases that are partitioned at the replication fork
during translesion DNA synthesis. Genotoxic insults can lead to damage that stalls or slows the replication fork. Signaling through the
ATM and ATR kinases leads to the recruitment of nonessential “bypass” polymerases. The Y-family pols appear to be the primary means of
synthesizing past DNA lesions at stalled or collapsed replication forks but misregulation of these enzymes can lead to events that promote
mutagenesis and ultimately tumorigenesis. The exquisite regulation of Y-family DNA polymerases is vital to cellular survival in the face of
DNA damage and in the prevention excessive mutagenesis. Two DNA polymerase structures are shown, that of the catalytic subunit of the
B-family member yeast pol δ in ternary complex with 12/16-mer DNA (gray) and an incoming dCTP (yellow) (pdb id code 3IAY; [42]).
The Y-family polymerase Dpo4 from S. solfataricus is also shown in ternary complex with 13/18-mer DNA (gray) and an incoming ddATP
(pdb id code 1JX4; [43]). Both enzymes possess the core the palm (cyan), ﬁnger (red), and thumb (green) domains. Pol δ also has a 3  to 5 
exonuclease domain (magenta), as well as the N-terminal domain (dark blue). The little ﬁnger domain (orange) is unique to the Y-family.
with ∼100-fold reduction in catalytic eﬃciency [38]. Both
human and yeast pol η preferentially insert dGTP opposite
THF with a large (∼103)d e c r e a s ei ne ﬃciency, but the
preference for dGTP is only very small for human η,a s
dATP insertion opposite THF is about the same as dGTP
[39]. Human pol κ catalytic eﬃciency decreases ∼104 when
attempting to insert opposite THF, although the addition of
accessory factors such as PCNA, RFC, and RPA increases the
eﬃciency ∼40-fold [40]. Human pol ι inserts either dGTP
or dTTP opposite THF with ∼10-fold reduction in eﬃciency
[41].
One issue with the THF studies is that bypass of natural
abasicsitesinvolvesprimarilyaccuratebypass(the“C-rule”),
which appears to depend on the action of REV1 (Figure 3)
[44]. Because depurination is much more frequent than
depyrimidination and guanine is the base more likely to
depurinate (generating an abasic site), there is an intellectual
attraction to the concept that an enzyme that primarily
insertsdCTP(regardlessofthetemplatebaseidentity)would
be involved in bypass of abasic sites. This model highlights
the role of the deoxycytidyl transferase activity of REV1 in
“accurate” bypass of abasic sites. REV1 catalyzes phosphoryl
transfer in a protein template-dependent manner by using
an arginine residue to pair with dCTP [45]. Consequently,
the REV1 enzyme primarily (but not exclusively) catalyzes
incorporation of dCTP, regardless of the identity of the
template sequence.
Cells are constantly exposed to exogenous and endoge-
nous sources of oxidative damage to DNA [31, 46, 47]. Gua-
nine is the most readily oxidized base in the genome and 7,8-
dihydro-8-oxo-2 -deoxyguanosine (8-oxodG) (Figure 1(a))
has long been considered a classical marker of oxidative
damage to the genetic code [48]. The 8-oxodG adduct
is strongly mutagenic in bacterial and eukaryotic cells,
inducing primarily G to T transversions [49]. At least four
pathways prevent 8-oxodG adducts or 8-oxodG:A mispairs
from accumulating in the eukaryotic genome [50–54]. In
vitro analysis of DNA and RNA polymerase activity oppositeJournal of Nucleic Acids 5
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the lesion has provided some insight into mechanisms of
8-oxodG bypass. In general, most DNA polymerases tested
show either a preference for incorrect insertion of dATP or
are kinetically indiﬀerent to dCTP or dATP [55–60]. Some
notable exceptions to this rule have been documented: (i)
Saccharomyces cerevisiae DNA polymerase η [61–63]a n d
(ii) Dpo4, the dinB homologue from the crenarchaeote
Sulfolobus solfataricus [64–66]. These enzymes are at least
20-fold more eﬃcient at accurate bypass of 8-oxodG than
incorrect insertion of dATP (Figure 3). It is also notable that
the ﬁdelity of 8-oxodG bypass by human pols λ and η is
increased (100-fold and 27-fold, resp.) by the inclusion of
the accessory factors PCNA and RPA [63]. Both human pol
ι and REV1 perform relatively accurate bypass of 8-oxodG
by preferentially inserting dCTP with only moderate loss of
eﬃciency [67, 68].
The apparent functional superiority of Dpo4 and pol η at
maintaining genomic integrity during bypass of 8-oxodG is
atleastpartlyduetoanelectrostaticcontactbetweenthelittle
ﬁnger domain and the O8 atom of 8-oxodG [64]. Crystal
structures with Dpo4 in complex with 8-oxodG modiﬁed
DNA template reveal that Arg-332 forms a hydrogen bond
with the O8 atom of 8-oxodG, which apparently stabilizes
the normal anti conformation around the glycosidic bond
and presents the unperturbed Watson-Crick face of the base
to the incoming dNTP. Super-imposition of yeast pol η with
Dpo4 suggests that Lys-498 may provide a similar function
to Arg-332. At the nucleoside level, 8-oxoG preferentially
adopts the syn orientation that will present the Hoogsteen
edge of the base to the incoming dNTP in the active site
of polymerases [69]. The syn 8-oxodG:dA pairing mode
has been observed for many polymerases, including Dpo4
[55, 66]. However, stabilization of the anti mode for 8-
oxodG by Dpo4 results in an energy of activation value
that is actually lower for Dpo4-catalyzed insertion of dCTP
opposite 8-oxodG than dCTP insertion opposite dG, thereby
favoring accurate bypass [66].
In contrast to Dpo4, the human DinB homologue pol
κ is quite error-prone at bypass of 8-oxoG, preferentially
inserting dATP opposite the lesions [70]. There are at
least three distinct molecular features that distinguish the
activities of Dpo4 and pol κ during insertion opposite
8-oxodG [70]. The ﬁrst distinction can be found in the
little ﬁnger residue Arg-332 that stabilizes anti 8-oxodG in
Dpo4. In pol κ the analogous residue is Leu-508, which
obviously cannot mediate electrostatic stabilization of anti
8-oxodG. Mutating Leu-508 to lysine shifts the kinetic
preference towards accurate insertion of dCTP opposite 8-
oxodG. The second distinction resides in the fact that the
active site of pol κ is sterically more constrained than Dpo4,
especially in considering the residues that form the “roof”
over the nascent base pair. Residues Phe-155, Ser-134, Pro-
153, Met-135, and Ala-151 from the ﬁnger domain of pol
κ correspond to Val-62, Gly-41, Pro-60, Ala-42, and Gly-
58 in Dpo4. The active site of pol κ only accommodates
a single template residue. The third distinction between6 Journal of Nucleic Acids
pol κ and Dpo4-catalyzed bypass of 8-oxodG is inferred
from kinetic and structural diﬀerences between these two
enzymes. The most striking structural diﬀerence between
pol κ and Dpo4 is the N-terminal extension called the “N-
clasp” in pol κ that is vital to polymerase activity. Dpo4
has no analogous domain. The N-clasp sits a top the DNA
binding cleft, encircling the DNA, and serves to stabilize
the position of the little ﬁnger domain relative to the
polymerase core domains. The contacts made between the
N-clasp, the ﬁnger, and little ﬁnger domains are presumably
limiting conformational ﬂuctuations near the template DNA
binding region. Thus, the more thermodynamically stable
syn orientation of 8-oxoG will therefore be more diﬃcult
to shift back to the anti form (i.e., the mode ideal for
accurate insertion of dCTP) in the pol κ active site relative
to Dpo4.
3. Major and Minor Groove DNA Adducts
The site of adduct formation on heterocyclic purine/pyr-
imidine residues is an important determinant of whether
the lesion will be blocking or whether a given polymerase
will perform synthesis in an accurate or inaccurate manner.
Most replicative DNA polymerases have contacts with the
hydrogen bond accepting atoms of purines and pyrimidines
on the minor groove portion of the dsDNA (N3 for purines
and O2 for pyrimidines) near the active site and are
consequently strongly impeded by minor groove adducts
[71]. Y-family polymerases do not possess an analogous
minor groove check upon base pair geometry, which when
combined with a more spacious active site results in a greater
ability to tolerate bulky minor groove DNA adducts.
The N2 atom of guanine is located on the minor
groove side of double-stranded (ds) DNA and is sus-
ceptible to modiﬁcation by α,β-unsaturated aldehydes
such as, acrolein, crotonaldehyde, malondialdehyde, and
trans-4-hydroxynonenal, as well as oxidation products of
heterocyclic aromatic amines (e.g., N-hydroxy-2-amino-
3-methylimidazo[4,5-f]quinoline) and polycyclic aromatic
hydrocarbons (e.g., benzo[a]pyrene) [72–75]. The eﬀect
of minor groove adduct bulk on the kinetics of Y-family
or replicative polymerase catalysis has been studied in a
systematic manner by increasing the size of a series of
dG adducts from N2-methyl(Me)dG to N2-methylenyl(6-
benzo[a]pyrenyl)dG (N2-BPdG) (Figure 1(b))[ 76–80]. Of
course, adducts can also form on the major groove [81]. The
eﬀect of adduct size on the major groove side was studied for
the Y-family and replicative polymerases using O6-(Ar)alkyl-
dG adducts ranging in size from O6-methyl-dG (O6-MedG)
to O6-pyridyloxobutyl-dG (O6-PobdG) (Figure 1(c))[ 80,
82].
Kinetic and structural work with the model Y-family
DNA polymerase Dpo4 provides an initial framework
for understanding bypass of minor groove DNA adducts.
Unlike model replicative polymerases (i.e., A- and B-family
polymerases from model organisms such as, bacteriophage
T7 and RB69), which are severely inhibited by even the
small N2- M e Ga d d u c t ,D p o 4i sa b l et ob y p a s sas e r i e s
of minor groove adducts with negligible inhibitory eﬀects
on catalytic eﬃciency and moderate eﬀects upon ﬁdelity
[83]. Two crystal structures of Dpo4 in complex with the
bulky N2-methylenyl-(2-naphthyl)-dG (N2-CH2-Naph-dG)
adducted DNA have been reported [83]. Interestingly, the
N2-CH2-Naph-dG adduct was found to adopt two distinct
postinsertion orientations in complexes that should be
identical. One structure placed N2-CH2-Naph-dG in the
anti-orientation, which forces the cytosine residue at the
primer terminus out of the active site into the growing
minor groove face. The second structure revealed N2-CH2-
Naph-dG rotated into the syn orientation, which allows the
N4 exocyclic amino group of cytosine to form a bifurcated
HoogsteenpairwiththeN7andO6atomsofN2-CH2-Naph-
dG. Since the ﬁdelity of Dpo4 bypass of N2-CH2-Naph-dG
is only diminished ∼2-fold relative to dG, it seems likely
that the productive conformation involves the anti oriented
adduct paired in normal Watson-Crick mode with dCTP
and that the crystal structures failed to reveal the true active
conformation. These structural results are indicative of the
conformational heterogeneity that most likely accompanies
many DNA adduct bypass events.
Like Dpo4, all four human Y-family DNA polymerases
show fairly remarkable tolerance of minor groove DNA
adducts when compared to model replicative enzymes. The
eﬃciency and ﬁdelity of pol η bypass are not reduced much
by N2-bulk equal to or smaller than the N2-CH2-Naph-
dG adduct, but it is severely perturbed by N2-dG adducts
larger than a methylenyl(9-anthracenyl) group in the minor
groove [76–78, 80]. REV1 and pol κ provide the most
accurate and catalytically tolerant means of bypassing of
minor groove bulk at the guanine N2 atom at least up to a
benzo[a]pyrene group (N2-CH2-BPdG) (Figure 3)[ 76, 80]
but probably for diﬀerent molecular reasons. The REV1
catalytic eﬃciency (kcat/Km,dNTP) is barely reduced at all
during dCTP insertion opposite N2-CH2-BPdG relative to
dG [80], presumably due to the fact that REV1 uses the N-
terminal domain called the “N-digit” to ﬂip the template
base out of the polymerase active site, which results in
the pairing of dCTP opposite an arginine in the N-digit.
Pol κ, on the other hand, is most likely stabilizing the
N2-(ar)alkyl dG adducts in the minor groove through an
interaction with the N-clasp. In contrast to the N-digit of
REV1 (which resides on the minor groove side of the DNA
binding cleft), the N-clasp sits on top of the polymerase
active site [84]. An in vitro comparison of pol κ-catalyzed
bypass of N2-BPdG and N6-BPdA adducts clearly showed
that the minor groove N2-BPdG was bypassed eﬃciently
(regardless of adduct stereochemistry), while N6-BPdA was
a complete block to pol κ activity [85]. The results from a
recent molecular modeling study are consistent with the idea
that the N-clasp of pol κ plays a central role in facilitating
accurate bypass of N2-BPdG adducts [86]. The modeling
work suggests that anti-oriented N2-BPdG is stabilized in
the minor groove because there are close contacts with the
N-clasp if N2-BPdG is positioned in the major groove by
adopting the syn-orientation. Moreover, there appears to
be a phenylalanine residue conserved only in pol κ (Phe-
151) and REV1 (Phe-543) that may form base-stackingJournal of Nucleic Acids 7
interactions with the benzo[a]pyrene ring system, favoring
minor groove stabilization during accurate bypass of the
adduct.
Bypass of major groove O6-(Ar)alkyl-dG DNA adducts,
at least up to O6-benzyldG (O6-BzdG), is performed eﬃ-
ciently by human pol ι (Figure 3) but this reaction is highly
error-prone (i.e., insertion of dTTP is the major product
for both O6-MedG and O6-BzdG), and pol ι eﬃciency is
decreased 300-fold by O6-PobdG [82]. Other DNA poly-
merases, including pol δ (with PCNA), are able to bypass
adducts in the major groove but the catalytic eﬃciency of
these events appears to be more perturbed than with pol
ι. Human replicative pol δ (with PCNA) appears to better
accommodateandbypassmajorgrooveO6-BzGadducts[82]
than minor groove N2-BzG adducts [77–80, 82]. In contrast,
most of human Y-family DNA polymerases except for pol ι
can bypass minor groove N2-G adducts [76–80]m u c hm o r e
eﬃciently than major groove O6-G adducts [82]. Human
pol κ was found to be the DNA polymerase most inhibited
by the major groove-protruding O6-(Ar)alkyl dG adducts,
consistent with the N6-BPdA results and further suggesting
a role for the N-clasp in pol κ functionality. Dpo4 can bypass
O6-MedG and O6-BzdG adducts in a catalytically perturbed
(i.e., the eﬃciency is decreased 14- to 62-fold for each of
the adducts) but mostly accurate manner (∼70% accurate
insertionofdCTP)[87,88].TheeﬃciencyofDpo4-catalyzed
bypass of bulky N6-adenyl polycyclic aromatic hydrocarbon
(PAH) adducts is reduced several hundred fold and results
in a mixture of error-free and error-prone products [89].
By way of comparison, the high-ﬁdelity bacteriophage T7−
DNA polymerase is inhibited over 2,000-fold by N6-dA-PAH
adducts [90]. Crystal structures of Dpo4 in complex with
O6-(Ar)alkyl-dG modiﬁed DNA reveal that accurate bypass
of these adducts proceeds through a “wobble” base pairing
between dC and the O6-(ar)alkyl-dG adduct. Work with
the (+)-transand (−)-trans-N6-BPdA adducts indicated that
human pol η was quite eﬃcient at bypassing the (+)-trans
stereoisomer in what appears to be an accurate manner but
was essentially blocked by the (−)-trans stereoisomer of the
N6-BPdA adduct [85]. The exact structural rationale for the
results with pol η and major groove dA adducts remains
unknown. Interestingly, pol η but not pol ι nor κ can copy
past O6-PobdG [82]a sw e lla st h eC8-dG adduct of 2-amino-
3-methylimidazo[4,5-f]quinoline (IQ) [61], indicating the
versatile bypass activity of pol η past various DNA lesions
such as major and minor groove DNA adducts, ring-closed
exocyclic DNA adducts (vide infra), as well as pyrimidine
dimers.
4. ExocyclicDNA Adducts
Exocyclic DNA adducts can be formed through many
of the same chemical and biological processes that form
major/minor groove adducts, namely, electrophilic lipid
oxidation products and products arising from oxidation of
DNA [73, 91]. Of particular interest is the 3-(2 -deoxy-β-D-
erythro-pentofuranosyl)pyrimido[1,2-a]purin-10(3H)-one
(M1dG) adduct (Figure 1(d)) arising from exposure to
the bis-electrophile malondialdehyde or base propenals
that arise following treatment with chemicals such as
bleomycin [92–94]. The M1dG adduct has been detected
at levels of 5,400 adducts per liver cell in the DNA of
healthy humans [95]. This adduct is a particularly insidious
impediment to genomic integrity because it can ring-open
when paired opposite cytosine in dsDNA [96], which
may mask its presence from detection by DNA repair
pathways. In single-stranded (ss) DNA, the ring-opened
N2-oxopropenyl-2 -deoxyguanosine (N2-OPdG) form
closes to M1dG, blocking the Watson-Crick edge of the
guanine base. M1dG is mutagenic in both bacterial and
mammalian cells, producing mainly G to T transversions
but also resulting in −1 frameshift deletions [97]. Studies
with Y-family DNA polymerases indicate that pol η is the
most likely candidate for producing the G to T transverions
in mammalian systems (Figure 3)[ 98]. Both pols ι and κ
are relatively accurate when bypassing M1dG, and while
pol κ showed preferential insertion of dCTP there was
a strong level of inhibition relative to catalysis opposite
dG (Maddukuri, L., Eoﬀ, R.L., Choi, J-Y., Rizzo, C. J.,
Guengerich, F. P., and Marnett, L.J., Biochemistry in press).
C r y s t a ls t r u c t u r e sh a v eb e e ns o l v e dw i t hD p o 4i nc o m p l e x
with M1dG modiﬁed template DNA [99]. Like human pol η,
Dpo4 preferentially inserts dATP opposite M1dG, although
the catalytic eﬃciency of this reaction is diminished 260-
to 430-fold relative to normal insertion of dCTP opposite
template dG. The M1dG adduct is in the ring-closed form
in both Dpo4 ternary structures reported, even though the
primer in one complex was designed to pair a 3 -terminal
cytosine residue with M1dG.
1,N2-Etheno (ε)d G( Figure 1(d)) is another mutagenic
exocyclic DNA adduct formed through the reaction of
DNA with reactive chemicals (e.g., epoxides formed from
oxidation of vinyl chloride and urethane) and endogenous
products of lipid peroxidation [100–103]. The 1,N2-ε-
dG adduct, like the ring-closed M1dG adduct, blocks the
Watson-Crick edge of guanine. Similar to M1dG bypass,
human pols η and ι can bypass 1,N2-ε-dG and generate
misinsertion errors (G and T, resp.), but pol κ was severely
inhibited in catalysis [76]. Biochemical studies with Dpo4
showed that the major products arising from bypass of
1,N2-ε-dG are dATP misinsertions and −1 frameshift dele-
tions [104]. In the same study, crystal structures revealed
that Dpo4 readily skips past the 1,N2-ε-dG adduct with
no major perturbations to the polymerase active site. A
similar so-called “type II” structure was solved for Dpo4
in complex with M1dG-containing template DNA [99].
As noted earlier, there are no hydrogen bonds between
the purine/pyrimidine rings of the nascent base pair and
amino acid side chains in the Dpo4 active site to inﬂu-
ence base pair geometry. Recent work has highlighted the
importance of base-stacking between the primer-template
junction and the nascent base pair during Dpo4-catalyzed
generation of −1 frameshift deletions [83]. Presumably
the same phenomenon is playing a signiﬁcant role in
determining the outcome of Dpo4-catalyzed bypass of
exocyclic DNA adducts and perhaps other Y-family DNA
polymerases.8 Journal of Nucleic Acids
5. Summary andOutlook
Many questions remain regarding the biological impor-
tance of individual DNA polymerases during bypass of
speciﬁc DNA lesions. In vitro experimentation with puri-
ﬁed recombinant enzymes can certainly establish what is
possible in nature but may not represent what is most
likely to occur in vivo. The mechanisms that regulate how
and when specialized DNA polymerases gain access to
damaged template DNA are complex, and many elements
of these pathways remain to be elucidated. Mechanistic
studies related to adduct bypass in diﬀerent sequence
contexts might also be very helpful in developing a greater
understanding of mutations hotspots and the relationship
of mutations to cancer. Finally, the importance of Y-
family DNA polymerases in the processing of non-B form
DNA is an area of active interest because these types of
structuresareintimatelylinkedtothemanifestationoffragile
sites in the genome, as well as in rearrangements that
occur in the promoter regions of tumor suppressors and
oncogenes.
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